$LPCN
Lipocine Inc.

2013 Q4 Form 10-Q Financial Statement

#000119312513438833 Filed on November 13, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.030M $1.180M $0.00
YoY Change 11700.0% -100.0%
% of Gross Profit
Research & Development $2.460M $1.569M
YoY Change 186.4%
% of Gross Profit
Depreciation & Amortization $0.00 $10.00K
YoY Change -66.67%
% of Gross Profit
Operating Expenses $3.500M $3.546M $0.00
YoY Change 547.25% -100.0%
Operating Profit -$3.546M
YoY Change 249.34%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $20.00K $20.00K
YoY Change
Pretax Income -$4.390M -$3.531M $0.00
YoY Change 35206.81% -100.0%
Income Tax $0.00 -$55.34K $0.00
% Of Pretax Income
Net Earnings -$4.390M -$3.475M $0.00
YoY Change 243.12% -100.0%
Net Earnings / Revenue
Basic Earnings Per Share -$0.39
Diluted Earnings Per Share -$379.1K -$0.39 $0.00
COMMON SHARES
Basic Shares Outstanding 11.06M shares 8.915M shares
Diluted Shares Outstanding 8.915M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.26M $36.84M $0.00
YoY Change -100.0%
Cash & Equivalents $45.26M $36.84M $5.377M
Short-Term Investments
Other Short-Term Assets $770.0K $250.0K $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $46.03M $37.09M $5.472M
YoY Change 741.28% 18139.54%
LONG-TERM ASSETS
Property, Plant & Equipment $28.79K $34.84K $49.36K
YoY Change -41.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $45.00K $45.00K $45.00K
YoY Change 0.0%
Total Long-Term Assets $73.79K $79.84K $94.36K
YoY Change -21.79%
TOTAL ASSETS
Total Short-Term Assets $46.03M $37.09M $5.472M
Total Long-Term Assets $73.79K $79.84K $94.36K
Total Assets $46.11M $37.17M $5.566M
YoY Change 728.35% 18454.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.027M $1.483M $87.03K
YoY Change 1080.12% 14733.34% 770.27%
Accrued Expenses $256.8K $145.0K $108.0K
YoY Change 137.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.284M $1.628M $212.8K
YoY Change 503.24% 16183.11% 2028.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.284M $1.628M $212.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.284M $1.628M $250.0K
YoY Change 413.46% 16183.11% 2400.25%
SHAREHOLDERS EQUITY
Retained Earnings -$47.86M -$43.47M -$37.27M
YoY Change 28.41%
Common Stock $1.267K $1.095K $446.00
YoY Change 184.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares 0.000 shares
Shareholders Equity $44.82M $35.54M $5.316M
YoY Change
Total Liabilities & Shareholders Equity $46.11M $37.17M $5.566M
YoY Change 728.35% 18454.06%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income -$4.390M -$3.475M $0.00
YoY Change 243.12% -100.0%
Depreciation, Depletion And Amortization $0.00 $10.00K
YoY Change -66.67%
Cash From Operating Activities -$4.110M -$2.760M $2.080M
YoY Change -297.6% 32.69% -20900.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.54M 35.99M 40.00K
YoY Change 31250.0% -90075.0% 33.33%
NET CHANGE
Cash From Operating Activities -4.110M -2.760M 2.080M
Cash From Investing Activities 0.000 0.000 10.00K
Cash From Financing Activities 12.54M 35.99M 40.00K
Net Change In Cash 8.430M 33.23M 2.130M
YoY Change 295.77% -1660.09% 10550.0%
FREE CASH FLOW
Cash From Operating Activities -$4.110M -$2.760M $2.080M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$4.110M -$2.760M
YoY Change 33.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
LPCN
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11056377 shares
dei Entity Registrant Name
EntityRegistrantName
Lipocine Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001535955
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2012Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
3815 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
37090775 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
5471863 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34836 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49355 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1483334 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
87027 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
144977 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
107950 USD
CY2013Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17836 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1628311 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
212813 USD
CY2013Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
0 USD
CY2012Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
37212 USD
CY2013Q3 us-gaap Liabilities
Liabilities
1628311 USD
CY2012Q4 us-gaap Liabilities
Liabilities
250025 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
1095 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
446 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
79015280 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42590042 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43474075 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37274295 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
35542300 USD
CY2012Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2295 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4764987 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
171 USD
CY2012Q4 us-gaap Assets
Assets
5566218 USD
CY2013Q3 us-gaap Assets
Assets
37170611 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-55048 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1581 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-1012877 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
467180 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.04
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8914666 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4455790 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5377114 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
90934 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
5316193 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37170611 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5566218 USD
CY2013Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
CY2012Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
0 USD
us-gaap License And Services Revenue
LicenseAndServicesRevenue
7523437 USD
CY2013Q3 lpcn Research Revenue
ResearchRevenue
0 USD
CY2012Q3 lpcn Research Revenue
ResearchRevenue
0 USD
lpcn Research Revenue
ResearchRevenue
0 USD
lpcn Research Revenue
ResearchRevenue
186233 USD
CY2013Q3 us-gaap Revenues
Revenues
0 USD
CY2012Q3 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
7709670 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1568969 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
547821 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2657936 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1696428 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1181894 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2601557 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1256691 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3545765 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1015001 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6271123 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4756551 USD
CY2013Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
15084 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-3475339 USD
us-gaap Net Income Loss
NetIncomeLoss
-6199780 USD
us-gaap Net Income Loss
NetIncomeLoss
4763406 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8914666 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4455790 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5958415 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4455790 shares
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5958415 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4455790 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15725 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
31594 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
3815 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
758767 USD
us-gaap Share Based Compensation
ShareBasedCompensation
116844 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-291198 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
160815 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14908 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
808632 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1124921 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
152567 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
37027 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10131 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-55048 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
513 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7523437 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4475388 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2138889 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1206 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12386 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1206 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12386 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31461912 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2151275 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8567823 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6416548 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1013367 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
997642 USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10952593 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4455790 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10952593 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4455790 shares
CY2013Q3 lpcn Reverse Merger Costs
ReverseMergerCosts
794902 USD
CY2012Q3 lpcn Reverse Merger Costs
ReverseMergerCosts
0 USD
lpcn Reverse Merger Costs
ReverseMergerCosts
1011630 USD
lpcn Reverse Merger Costs
ReverseMergerCosts
0 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-3387 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10576 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35981030 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
53100 USD
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35938506 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
lpcn Accured Common Stock Offering Costs
AccuredCommonStockOfferingCosts
271386 USD
lpcn Accured Common Stock Offering Costs
AccuredCommonStockOfferingCosts
0 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3475339 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1012877 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6199780 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4657611 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3475339 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1012877 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6199780 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4657611 USD
CY2013Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1933334 USD
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2686727 USD
CY2013Q3 lpcn Reversal Of Liability For Uncertain Tax Positions Current
ReversalOfLiabilityForUncertainTaxPositionsCurrent
55342 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
66281 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
247841 USD
CY2013Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
314122 USD
CY2013Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
88864 USD
CY2012Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
84952 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
266591 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
254857 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
946281 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
285527 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8610 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
4688 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1214749 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
899692 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.19
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.38
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.53
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.85
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M28D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M16D
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
160281 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36896 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
758767 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
116844 USD
CY2003Q4 lpcn Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
20467 shares
CY2003Q4 lpcn Class Of Warrant Or Right Exercise Price Of Warrants Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsIssued
12.21
CY2003Q4 lpcn Class Of Warrant Or Right Amended Expiration Date
ClassOfWarrantOrRightAmendedExpirationDate
2015-12-31
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
160281 USD
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
36896 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3.55 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2.06 shares
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
105795 USD
us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
0 USD
CY2013Q3 us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
0 USD
CY2012Q3 us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
0 USD

Files In Submission

Name View Source Status
0001193125-13-438833-index-headers.html Edgar Link pending
0001193125-13-438833-index.html Edgar Link pending
0001193125-13-438833.txt Edgar Link pending
0001193125-13-438833-xbrl.zip Edgar Link pending
d614851d10q.htm Edgar Link pending
d614851dex311.htm Edgar Link pending
d614851dex312.htm Edgar Link pending
d614851dex321.htm Edgar Link pending
d614851dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lpcn-20130930.xml Edgar Link completed
lpcn-20130930.xsd Edgar Link pending
lpcn-20130930_cal.xml Edgar Link unprocessable
lpcn-20130930_def.xml Edgar Link unprocessable
lpcn-20130930_lab.xml Edgar Link unprocessable
lpcn-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending